JAMA APC and Open Access: Two Journals, Two Price Points, and How to Get Coverage
JAMA charges ~$5,500 for open access. JAMA Network Open is $3,000 gold OA. AMA institutional deals, waivers, and full cost breakdown.
Senior Researcher, Oncology & Cell Biology
Author context
Specializes in manuscript preparation and peer review strategy for oncology and cell biology, with deep experience evaluating submissions to Nature Medicine, JCO, Cancer Cell, and Cell-family journals.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Quick answer: The JAMA flagship charges around $5,500 for gold open access. JAMA Network Open, the AMA's fully OA journal, costs $3,000 per article. If you don't need open access for the flagship, subscription-track publication is free. The two journals serve different purposes, and the cost structure reflects that.
What JAMA actually charges
JAMA operates under the American Medical Association (AMA), and its APC structure splits across two main titles:
Journal | APC (USD) | Model |
|---|---|---|
JAMA (flagship) | ~$5,500 | Hybrid (OA optional) |
JAMA Network Open | ~$3,000 | Gold OA (always paid) |
JAMA specialty journals (e.g., JAMA Oncology, JAMA Cardiology) | ~$5,000 | Hybrid |
The flagship APC is charged at acceptance, not at submission. You won't see a payment request during peer review. If you publish via the subscription track, you pay nothing.
One thing that sets JAMA apart from Nature or NEJM: the flagship APC is notably lower. At $5,500, JAMA costs less than half of Nature's $12,850 and roughly half of NEJM's ~$10,000. For a journal with an impact factor of 55.7, that's a competitive price point.
The hybrid model: subscription vs. open access
JAMA is a hybrid journal. Most authors publish through the subscription track:
- Subscription track (default, $0): Your article appears behind the JAMA paywall. Institutional subscribers and AMA members have access. After 12 months, JAMA makes research articles freely available on its website.
- Gold OA track (~$5,500): Your article is immediately free to read under a Creative Commons license. You or your funder pays the APC.
The 12-month embargo matters. Unlike NEJM (which frees articles after 6 months), JAMA holds content behind the paywall for a full year. If immediate public access matters to you or your funder, the $5,500 OA route is your option.
That said, JAMA's subscriber base is enormous. Over 300,000 physicians receive JAMA directly, and virtually every academic medical library subscribes. Your article will be read by clinicians who need it, paywall or not.
JAMA Network Open: the gold OA alternative
If you want guaranteed open access without the hybrid complexity, JAMA Network Open is worth considering. Launched in 2018, it's now one of the largest gold OA medical journals:
- APC: $3,000
- Model: Fully gold OA (every article is free from day one)
- License: CC BY
- Impact factor (2024): ~10.5
- Acceptance rate: Roughly 12-15%
- Scope: All areas of medicine, public health, and health policy
JAMA Network Open publishes over 2,000 articles per year and has built a strong reputation fast. For researchers who need Plan S compliance and don't want to pay $5,500 for the flagship's OA option, it's a legitimate alternative. The trade-off is prestige and impact factor, not rigor.
Institutional agreements
The AMA has been building its institutional agreement portfolio, though it's still smaller than Springer Nature's network. Here's the current landscape:
Region / Institution Type | Coverage Status | Notes |
|---|---|---|
US academic medical centers | Growing | Individual institutional deals; no national consortium |
UK (Jisc) | Active | Covers JAMA titles for UK institutions |
Germany (DEAL) | Limited | Not as broad as the Springer Nature DEAL agreement |
Australia (CAUL) | Some coverage | Select institutions |
Netherlands | Active | Through national consortium |
Developing countries | Waiver-based | Not agreement-based; handled through APC waivers |
The US landscape is fragmented. Some large medical schools (Harvard, Johns Hopkins, UCSF) have negotiated coverage. Others haven't. Before choosing OA at JAMA, contact your library's scholarly communications team and ask specifically about AMA journal coverage.
One detail that trips people up: an Elsevier or Springer Nature agreement at your institution tells you nothing about JAMA. The AMA is an independent publisher. You need an AMA-specific deal.
Waivers and discounts
The AMA's waiver policy is more structured than some publishers:
Automatic geographical waivers:
- Authors from World Bank low-income countries receive a full APC waiver for all JAMA Network journals.
- Authors from lower-middle-income countries receive partial fee reductions (typically 50% or more).
Case-by-case hardship waivers:
- Available upon request at the time of acceptance.
- The AMA states that editorial decisions are completely independent of waiver requests.
- Approval rates aren't published, but the AMA has a better reputation for waiver accessibility than some larger commercial publishers.
No society membership discounts:
- AMA membership doesn't reduce the APC. The fee is the same regardless of membership status.
For researchers at well-funded institutions in high-income countries, the expectation is that your grant or institutional agreement covers the cost. The waiver system is designed for authors who genuinely lack funding, not for labs that prefer not to spend grant money on APCs.
Funder mandate compliance
Funder/Policy | Compliant? | Route |
|---|---|---|
Plan S (cOAlition S) | Yes | Gold OA with CC BY at JAMA (~$5,500) or publish in JAMA Network Open ($3,000) |
NIH Public Access | Yes | Gold OA or green OA (PMC deposit after 12-month embargo, $0) |
UKRI | Yes | Gold OA with CC BY |
ERC | Yes | Gold OA with CC BY |
Wellcome Trust | Yes | Gold OA with CC BY (Wellcome typically covers the APC) |
HHMI | Yes | Gold OA with CC BY |
The NIH route is the most cost-effective for JAMA flagship: publish via subscription (free), deposit the accepted manuscript in PubMed Central after 12 months. This satisfies NIH policy without spending a dollar on APCs.
For Plan S compliance, you have two paths. Pay $5,500 for OA in the flagship, or submit to JAMA Network Open for $3,000. Both satisfy cOAlition S requirements. If your funder is paying and the research fits JAMA Network Open's scope, the $3,000 route saves real money.
JAMA supports CC BY and CC BY-NC licenses. Plan S requires CC BY. Select the right license during the production process, because changing it post-publication is difficult and not guaranteed.
How JAMA compares to peer journals
Journal | APC (USD) | Model | IF (2024) | Embargo | Institutional Deals |
|---|---|---|---|---|---|
JAMA | ~$5,500 | Hybrid | 55.7 | 12 months | Growing |
NEJM | ~$10,000 | Hybrid | 78.5 | 6 months | Very limited |
The Lancet | ~$6,500 | Hybrid | 88.5 | 12 months | Limited (excluded from most Elsevier deals) |
BMJ | ~$4,500 | Hybrid | 33.7 | Varies | Active (Jisc, others) |
Nature Medicine | $12,850 | Hybrid | 50.0 | 6 months | Extensive (Springer Nature R&P) |
JAMA sits in a sweet spot on price. It's cheaper than NEJM, Lancet, and Nature Medicine, with an impact factor that's competitive in general medicine. The main disadvantage is the 12-month embargo, which is longer than NEJM's 6 months and tied with the Lancet.
If your primary concern is minimizing OA costs while publishing in a top-tier medical journal, JAMA offers the best ratio of prestige to APC among the big four. BMJ is cheaper ($4,500) but carries a lower impact factor.
The JAMA specialty journal landscape
JAMA's brand extends across 13 specialty journals. Their APCs cluster around $5,000 for hybrid OA:
Journal | APC (USD) | Model | IF (2024) |
|---|---|---|---|
JAMA Oncology | ~$5,000 | Hybrid | 22.5 |
JAMA Internal Medicine | ~$5,000 | Hybrid | 26.6 |
JAMA Cardiology | ~$5,000 | Hybrid | 14.8 |
JAMA Neurology | ~$5,000 | Hybrid | 18.6 |
JAMA Psychiatry | ~$5,000 | Hybrid | 18.5 |
JAMA Network Open | $3,000 | Gold OA | 10.5 |
The specialty journals are strong in their own right. JAMA Internal Medicine (IF 26.6) and JAMA Oncology (IF 22.5) are among the top journals in their fields. If your paper doesn't fit the flagship's generalist scope, one of these may be a better target with a similar APC.
Hidden costs
JAMA doesn't charge submission fees, page fees, or color figure charges. The APC (if you choose OA) is the only publication cost. But watch for these:
- Embargo vs. funder deadlines: JAMA's 12-month embargo is longer than many funders prefer. If your grant ends before the embargo lifts, you may need to budget for the OA fee rather than relying on the free green OA route.
- License selection errors: Choosing CC BY-NC when your funder requires CC BY creates a post-publication headache. The AMA can change licenses after the fact, but the process takes time and isn't automatic.
- JAMA Network Open is always paid: There's no subscription track. If your paper is accepted at JAMA Network Open, you will pay $3,000. Factor this into your submission strategy.
- Reprints: Physical reprints are charged separately. Most researchers don't need them, but some departments still request them for tenure files.
The practical decision
JAMA's cost structure is actually simpler than it looks:
- Funder requires immediate OA? Pay $5,500 for gold OA at the flagship, or target JAMA Network Open ($3,000) if your work fits.
- NIH-funded, no immediate OA mandate? Publish via subscription (free). Deposit in PMC after 12 months.
- Institution has an AMA agreement? Choose OA at the flagship. The APC is covered.
- No funder mandate, no institutional deal? Publish via subscription. JAMA's subscriber base ensures your paper reaches clinicians.
The harder question is whether your manuscript fits JAMA's editorial scope. JAMA prioritizes clinical research that affects general medical practice, major public health studies, and health policy with broad implications. The desk-rejection rate is over 85%.
If you're targeting the JAMA flagship or any JAMA specialty journal, check your manuscript's fit before submitting. Run a free readiness scan to catch the structural and framing issues that lead to desk rejection at this level. You can also learn more about how APC costs compare across publishers to make sure you're choosing the right journal for your budget and your science.
For the latest APC amounts and institutional agreements, check the AMA's official author resources page.
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Want the full journal picture?
Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.
These pages attract evaluation intent more than upload-ready intent.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Supporting reads
Conversion step
Want the full journal picture?
These pages attract evaluation intent more than upload-ready intent.